跳至主要内容
临床试验/DRKS00000565
DRKS00000565已完成未知

Malignant Arrhythmias and Adaptive Servoventilation in patients with congestive heart failure and Cheyne-Stokes respiration (MAAS-Trial) - MAAS

Kardiologische Klinik, Herz- und Diabeteszentrum NRW, Universitätsklinik der Ruhr-Universität Bochum0 个研究点目标入组 446 人开始时间: 2010年10月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
446

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 90 Years(—)
性别
All

入选标准

  • a persistent impairment of systolic left ventricular function according to echocardiographic criteria (LVEF = 45%)
  • - stable NYHA-class = II
  • - implanted cardioverter-defibrillator device (ICD)
  • - implanted cardiac resynchronization therapy device with cardiover-defibrillator (CRT-D) at least 6 months prior to enrollment
  • - stable heart failure medication for at least 4 weeks prior to enrolment and during follow-up

排除标准

  • - history of or ongoing treatment of SDB
  • - significant valvular heart disease
  • - evidence of moderate to severe pulmonary disease (FEV1/VC <70%)
  • - respiratory insufficiency reqiring permanent oxygen therapy
  • - hypercapnia (pCO2 > 45mmHg)
  • - pregnancy
  • - acute coronary syndrome
  • - acute myocardial decompensation
  • - therapy refractory restless legs syndrome

研究者

发起方
Kardiologische Klinik, Herz- und Diabeteszentrum NRW, Universitätsklinik der Ruhr-Universität Bochum

相似试验